Nipah pseudovirus system enables evaluation of vaccines in vitro and in vivo using non-BSL-4 facilities
ABSTRACTBecause of its high infectivity in humans and the lack of effective vaccines, Nipah virus is classified as a category C agent and handling has to be performed under biosafety level 4 conditions in non-endemic countries, which has hindered the development of vaccines. Based on a highly effici...
Main Authors: | Jianhui Nie, Lin Liu, Qing Wang, Ruifeng Chen, Tingting Ning, Qiang Liu, Weijin Huang, Youchun Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-01-01
|
Series: | Emerging Microbes and Infections |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/22221751.2019.1571871 |
Similar Items
-
HIV-1 pseudoviruses constructed in China regulatory laboratory
by: Jianhui Nie, et al.
Published: (2020-01-01) -
In vitro and in vivo efficacy of a Rift Valley fever virus vaccine based on pseudovirus
by: Jian Ma, et al.
Published: (2019-10-01) -
Sungai Nipah (Terengganu) [peta]
Published: (1962) -
Elicitation of immune responses against Nipah virus by an engineered synthetic DNA vaccine
by: Hyeree Choi, et al.
Published: (2022-11-01) -
Nipah Virus Infection Outbreak with Nosocomial and Corpse-to-Human Transmission, Bangladesh
by: Hossain M.S. Sazzad, et al.
Published: (2013-02-01)